🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

1,937 notícias encontradas para "year"
Portable PS-OCT scanner could reveal donor liver health without biopsy
Each year, thousands of patients in the United States wait for a liver transplant, while transplant teams must make rapid, difficult decisions about whether donor organs are suitable for use. Many of those livers, particularly from older or medically complex donors, require caref
Most obesity drugs do not improve quality of life or heart health, analysis indicates
Most obesity drugs do not improve quality of life or heart health, analysis indicates
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, and few show cardiovascular benefits at one year, according to an analysis of the latest evidence published by The BMJ.
Eight-patient Parkinson's stem cell clinical trial confirms feasibility
A landmark study led by Lund, Sweden, has shown that transplanting stem cell-derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects linked to the transplanted cells were seen during t
Long-term stroke data reveal stem cell therapy's safety, biological activity over years
Previously unpublished long-term clinical and imaging findings from participants treated with an induced pluripotent stem cell (iPSC)-derived neural progenitor cell therapy for chronic ischemic stroke were presented at the ISSCR 2026 Annual Meeting.
Huntington's treatment quest reaches first pluripotent stem cell trial, with safety now un
An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented at the ISSCR 2026 Annual Meeting. The Phase Ib/IIa REGEN4HD study represents a significant translational milestone following years of p
Data demonstrate 1-year survival of stem cell-derived neural progenitor cells in patients
New, previously unpublished clinical data have been presented at ISSCR 2026 demonstrating that transplanted human neural progenitor cells survived for at least one year following subretinal transplantation in patients with retinitis pigmentosa (RP), while maintaining a favorable
Foto: Nataliya Vaitkevich / Pexels
GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests
GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient popula
FDA expands use of first sickle cell disease gene therapy for children as young as 2 years
The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ages 2 and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent β thalassemia (TDT). Supplement
More pharmacists will be able to vaccinate children under 5. Here's what you need to know
More pharmacists will be able to vaccinate children under 5. Here's what you need to know
More children younger than 5 should be able to be vaccinated in pharmacies from January 2027 under a range of measures designed to boost vaccine coverage announced in this year's federal budget.
How random sounds played while sleeping impair memory formation
How random sounds played while sleeping impair memory formation
For several years now, sleep research has been focusing intensively on the question of whether targeted auditory stimulation during sleep can improve the consolidation of new memories. A research team in Freiburg led by the neuropsychologists Prof. Dr. Monika Schönauer and Dr. No
Bimekizumab well tolerated, efficacious over three years in axial spondyloarthritis
For patients with axial spondyloarthritis (axSpA), bimekizumab, a dual interleukin (IL)-17A and IL-17F inhibitor, is well tolerated over three years, according to a study published in the June issue of the Journal of Rheumatology.
Foundation fights medical errors that claim 200,000 US lives a year
Medical error is one of the leading causes of death in the United States, and one organization believes those deaths can be stopped.